Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Aug 7.
Published in final edited form as: Mol Cell. 2003 Jun;11(6):1673–1683. doi: 10.1016/s1097-2765(03)00232-6

Roles for RNA in Telomerase Nucleotide and Repeat Addition Processivity

Cary K Lai 1,1, Michael C Miller 1,1,2, Kathleen Collins 1,*
PMCID: PMC2917597  NIHMSID: NIHMS223124  PMID: 12820978

Summary

Telomerase is a ribonucleoprotein reverse transcriptase with two subunits critical for catalytic activity, the protein telomerase reverse transcriptase (TERT) and telomerase RNA. In this study, we establish additional roles of the telomerase RNA subunit by demonstrating that RNA motifs stimulate the processivity of nucleotide and repeat addition. These functions are both functionally and physically separable from the roles of other RNA motifs in establishing a properly defined template. Binding of Tetrahymena telomerase RNA stem IV to TERT enhances nucleotide addition processivity, while a cooperation of the RNA pseudoknot and stem IV promotes repeat addition processivity. The low processivity of DNA synthesis by telomerase ribonucleoproteins lacking the pseudoknot and/or stem IV can be rescued by addition of the deleted region in trans. These findings demonstrate RNA elements with roles in telomerase elongation processivity that are distinct from RNA elements that specify the internal template.

Introduction

Telomeres are DNA and protein structures that cap linear chromosomes, distinguishing authentic chromosome ends from DNA double-stranded breaks (reviewed in Chan and Blackburn, 2002; de Lange, 2002). In most eukaryotes, telomeric DNA consists of a tandem array of simple sequence repeats. De novo addition of telomeric repeats is necessary to counteract the incomplete replication of chromosome ends by DNA template-directed DNA polymerases. This telomere elongation is typically performed by the ribonucleoprotein (RNP) enzyme telomerase (reviewed in Blackburn, 2000).

The first telomerase component identified was the telomerase RNA from Tetrahymena thermophila. This 159 nucleotide RNA contains within it the sequence 3′-AACCCCAAC-5′ that serves as a template for synthesis of the telomeric repeat TTGGGG (Greider and Blackburn, 1989). Changes made to the sequence of the RNA template lead to changes in the sequence of telomeric repeat DNA in vitro and in vivo (Yu et al., 1990). In addition to the telomerase RNA, active telomerase RNPs also contain the protein telomerase reverse transcriptase (TERT). The central region of TERT has active site motifs shared among all reverse transcriptases (Lingner et al., 1997). The unique TERT N-terminal and C-terminal extensions harbor both phylogenetically conserved and variable motifs, many of unknown function (reviewed in Kelleher et al., 2002). The N terminus of at least the Tetrahymena and human TERTs harbors a domain responsible for high-affinity telomerase RNA binding (Bryan et al., 2000b; Lai et al., 2001). Mutagenesis of the Tetrahymena telomerase RNA implicates the region immediately 5′ of the template as the cognate high-affinity binding site for TERT. Interaction of the TERT RNA binding domain and this RNA element both creates a stable TERT-telomerase RNA complex and prevents dNTP addition past the normal 5′ template boundary (Lai et al., 2002; Licht and Collins, 1999).

In vitro DNA synthesis by most telomerases is nucleotide addition processive, producing product 3′ ends with a homogeneous telomeric repeat permutation that reflects synthesis to template 5′ boundary. For Tetrahymena telomerase, this results in the synthesis of products ending in the permutation GGGTTG (Figure 1A). Telomerases also can be repeat addition processive, adding multiple repeats to a single bound substrate before dissociation (Figure 1A). Reiterative repeat addition requires melting of the product-template hybrid, repositioning of the product 3′ end to the beginning of the template, and renewed engagement of the active site for nucleotide addition. The repeat addition processivity of several ciliate and mammalian telomerase holoenzymes and a minimal recombinant Tetrahymena telomerase RNP is stimulated allosterically by dGTP (Hammond and Cech, 1997; Maine et al., 1999; Hardy et al., 2001). The relative repeat addition processivity of telomerases from different organisms varies widely, at least as detected in vitro (Morin, 1989; Greider, 1991; Prowse et al., 1993; Cohn and Blackburn, 1995; Prescott and Blackburn, 1997). Whether this difference is physiologically relevant or is an artifact of assay conditions is not yet clear. A human telomerase inhibitor appears to induce proliferative senescence in cultured cancer cells primarily by interfering with repeat addition processivity (Pascolo et al., 2002). This suggests that human telomerase is normally repeat addition processive in vivo, and that an understanding of the mechanisms that govern repeat addition processivity could lead to improved anti-cancer drug development.

Figure 1. The 3′ Half of Tetrahymena Telomerase RNA Influences Nucleotide and Repeat Addition Processivity.

Figure 1

(A) Schematic of Tetrahymena telomerase RNA template and DNA products. The primer used here to enforce a unique template alignment, (TG)8TTGGG, is shown in capital letters; dNTPs added to synthesize product are shown in italic lower case letters. Product numbering refers to template positions during first repeat synthesis (+3 to +6) and to processive repeat addition in six-nucleotide increments (+12, etc.).

(B) Schematic of the secondary structure of Tetrahymena thermophila telomerase RNA. In gray are the regions of telomerase RNA with known template-related functions. The positions of telomerase RNA 3′ truncations are indicated according to the residue number of the new 3′ end. Secondary structure elements are indicated in Roman numerals (stems I–IV; stem III forms a pseudoknot).

(C) TERT was assembled with wild-type telomerase RNA (lane 1), 3′ truncated telomerase RNA (lanes 2–4), or no telomerase RNA (lane 5) before immunopurification and activity assay.

Previous mutagenesis studies of TERT have revealed important roles for protein side chains in elongation processivity. Substitutions within conserved reverse transcriptase motifs that are predicted to affect dNTP binding and positioning dramatically reduce nucleotide addition processivity (Miller et al., 2000; Bosoy and Lue, 2001). Substitutions in the TERT-specific C-terminal extension can also compromise nucleotide addition processivity (Peng et al., 2001; Hossain et al., 2002). A reverse transcriptase motif substitution that increased primer binding affinity also modestly increased repeat addition processivity (Bryan et al., 2000a).

Telomerase is frequently described as a protein enzyme with a “template RNA” that also serves accessory roles such as scaffolding protein recruitment to the holoenzyme. Indeed, TERT contains highly conserved reverse transcriptase active site residues that should coordinate the Mg2+ ions required for catalysis of dNTP addition (Lingner et al., 1997). Here, by studying RNA roles in recombinant telomerase activity, we show that telomerase is truly a cofunctional RNP. Previous studies using yeast, ciliate, and mammalian enzymes have demonstrated that nontemplate RNA motifs play critical roles in directing RNP assembly or in establishing a proper definition of template boundaries (Roy et al., 1998; Gilley and Blackburn, 1999; Mitchell and Collins, 2000; Peterson et al., 2001; Livengood et al., 2002; Seto et al., 2002; Tzfati et al., 2000; Lai et al., 2002). We now report that telomerase RNA surprisingly also has roles independent of RNP assembly and template definition, contributing key features of the catalytic specificity of DNA repeat synthesis.

Results

The 3′ Half of Tetrahymena Telomerase RNA Influences Elongation Processivity

Previous studies of recombinant Tetrahymena telomerase have identified specific functions for three sequence elements within the Tetrahymena telomerase RNA (Figure 1B). Located 5′ of the template is the TBE motif, designating its function as both TERT binding element and template 5′ boundary definition element (Lai et al., 2002). Immediately 3′ of the template is a template recognition element motif (TRE) that positions adjacent sequence in the active site for use as template (Miller and Collins, 2002). The TBE, template, and TRE are all near the 5′ end of the RNA and are predicted by phylogenetic comparison to be mostly single stranded (Romero and Blackburn, 1991). Truncation of the RNA 3′ end to position 107 (removing the last 52 nucleotides) deletes stem IV but leaves the TBE, template, and TRE intact. When combined with TERT, this RNA formed an active RNP (Figure 1C, lane 2). However, both the product profile and overall level of telomerase activity were different from when full-length telomerase RNA was used (Figure 1C, lane 1). More extensive 3′ truncation to position 63 also leaves intact all three of the telomerase RNA elements with template-related functions (Figure 1B). When combined with TERT, the 1-63 RNA formed an RNP with detectable telomerase activity (Figure 1C, lane 3) although activity was weaker than with 1-107 RNA. Truncation further, removing the TRE, reduced activity to an undetectable level (Figure 1C, lane 4), despite the fact that this truncated RNA could still bind to TERT (see below). These results are consistent with previous experiments using RNA sequence swaps and deletions in vivo (Bhattacharyya and Blackburn, 1997) and in vitro (Licht and Collins, 1999), which suggested that regions of the telomerase RNA outside of the TBE, template, and TRE play important but uncharacterized roles in enzyme activity.

The patterns of activity observed with the 1-63 and 1-107 RNAs suggested defects in nucleotide and repeat addition processivity. Tetrahymena telomerase typically produces a product profile with prominent products at six-nucleotide intervals (Figure 1C, lane 1). The primer used in the assays described here positions uniquely at the template such that the first nucleotide added is at the template +3 position (Figure 1A). In assays with wild-type telomerase RNA, 64% of the 32P-dGTP incorporation in the first repeat was +6 in length, whereas in assays with the 1-107 and 1-63 RNAs only 29% and 24% of the 32P-dGTP incorporation in the first repeat was +6 in length, respectively (Figure 1C). This +3 to +6 product profile was established within the first few minutes of an activity assay and did not change with additional reaction time, indicating that reaction time does not limit development of a product profile (Figure S1). These results suggest that stem IV plays some role in promoting nucleotide addition processivity. Telomerase RNPs with the 1-107 and 1-63 RNAs also did not efficiently elongate a primer by addition of more than one repeat (Figure 1C, lanes 2 and 3). In the standard assay conditions, products longer than +6 must derive from processive repeat addition due to the vast excess of unreacted primer. Therefore, stem IV of telomerase RNA seems to influence repeat addition processivity as well.

Stem IV Stimulates Nucleotide and Repeat Addition Processivity

The changes observed in telomerase activity could indicate that the 3′ end of the telomerase RNA plays specific roles in telomerase active site function. Alternatively, truncation of the 3′ end of the RNA could act in a nonspecific negative manner, for example by altering the global folding of the RNA to make the template less accessible. To differentiate between these alternatives, we took a complementation approach. We tested whether an RNA fragment containing only the 3′ end could restore processivity when added back to RNP assembled with 3′ truncated RNA. We reasoned that if we could add back a defined region of the telomerase RNA in trans to restore a specific aspect of catalytic specificity, we could establish which regions of the RNA are required for telomerase function independent of any potential role in cis-linked template definition.

Telomerase RNP with RNA lacking stem IV (1-107 RNA) exhibited weak nucleotide addition processivity and little if any repeat addition processivity (Figure 2B, lane 1). Addition in trans of a second telomerase RNA fragment containing stem IV restored both nucleotide addition processivity and repeat addition processivity to wild-type levels (Figure 2B, lanes 2 and 3). Telomerase RNP with an RNA that could not form stem IV or stem I (1-102 RNA) also was not repeat addition processive and was less nucleotide addition processive than RNP with 1-107 RNA (Figure 2B, lane 4). Addition of stem IV in trans to RNP with 1-102 RNA also restored substantial nucleotide and repeat addition processivity (Figure 2B, lanes 5 and 6). RNP with 1-102 RNA required the addition of higher concentrations of stem IV in trans to optimally stimulate repeat addition processivity (Figure 2B; data not shown). These results demonstrate that stem IV is required for elongation processivity and can function when cis-linked on the same RNA molecule as the template or when present in the activity assay as a separate RNA molecule.

Figure 2. Stem IV Stimulates Nucleotide and Repeat Addition Processivity.

Figure 2

(A) The structures of stems I and IV are shown. Nucleotides changed in the tetraloop substitution are shown in bold letters.

(B) TERT was assembled with the stem IV truncation RNAs 1-107 (lanes 1–3) or 1-102 (lanes 4–6). Added to the activity assay was no additional RNA (lanes 1 and 4) or 108-159 RNA at 5 μM (lanes 2 and 5) or 20 μM (lanes 3 and 6). Repeat addition processivity (R.A.P.) is indicated relative to that of the wild-type enzyme.

(C) Activity assays were performed using TERT assembled with wild-type telomerase RNA (lane 1), 3′ truncated telomerase RNA (lanes 2–6), or a UUCG tetraloop substitution of the distal loop of stem IV (lane 7).

(D) TERT was assembled with 1-107 RNA and then assayed with no additional RNA (lane 1) or the indicated stem IV RNA at 2 μM (lanes 2, 4, and 6) or 10 μM (lanes 3, 5, and 7).

The Distal Loop of Stem IV Stimulates Both Forms of Processivity

We next investigated whether a particular subregion within stem IV was sufficient to stimulate processivity. In the full-length RNA context, truncation of the 3′ end to position 146 did not alter the pattern of telomerase activity (Figure 2C, lanes 1–3). Further truncation to position 131, removing the distal loop of stem IV, eliminated repeat addition processivity and reduced nucleotide addition processivity (Figure 2C, lane 4). Truncation of the remaining sequence of stem IV had little if any additional impact (Figure 2C, lanes 5 and 6). To test the importance of the loop sequence alone, we created an RNA with a UUCG tetraloop in place of positions 132-138. The tetraloop-substitution RNA produced a similar level and pattern of activity as did removal of the entire stem IV (Figure 2C, lane 7). This finding is consistent with previous results demonstrating that sequence changes in the loop of stem IV affect the level of telomerase activity (Sperger and Cech, 2001).

Because stem IV stimulated nucleotide and repeat addition processivity when added in trans to a template-containing RNA (Figure 2B) and the sequence of the loop of stem IV appeared to be critical (Figure 2C), it seemed possible that just the distal end of stem IV could function in trans to rescue nucleotide and repeat addition processivity. We indeed found that RNA oligonucleotides representing positions 123-146 or 128-142 (Figure 2D, lanes 2–5) complemented defective processivity of RNP with 1-107 RNA as effectively as the entire stem IV (Figure 2D, lanes 6 and 7). We conclude that the distal loop of stem IV mediates stem IV function in nucleotide and repeat addition processivity.

The Stem III Pseudoknot and Stem IV Cooperate to Generate Repeat Addition Processivity

Previously, the distal loop of stem IV was shown to be important for stem III pseudoknot folding, suggesting a possible tertiary interaction between these telomerase RNA elements (Sperger and Cech, 2001). Based on this and other findings, we examined whether the stem III region is also important for nucleotide and/or repeat addition processivity. Truncation of the wild-type telomerase RNA 3′ end to position 63, removing stem III, decreased the level of RNP activity substantially relative to RNP with 1-107 RNA (Figure 1C, lanes 2 and 3). A role of stem III in nucleotide or repeat addition processivity was not possible to discern from this progressive 3′ truncation analysis, however, because 1-107 RNA lacking only stem IV was already compromised for both.

To investigate the role of stem III in the presence of stem IV, we tested the activity of template-containing RNAs with or without stem III when stem IV was present in trans. The low processivity of RNP with 1-102 RNA was rescued by trans complementation with an RNA containing stems III and IV (64-159 RNA) or an RNA containing stem IV alone (103-159 RNA) (Figure 3B, lanes 1–5). Either combination improved both nucleotide and repeat addition processivity. The same stem IV RNAs were also added in trans to RNP with 1-63 RNA. Addition of stem IV alone to 1-63 RNA rescued nucleotide addition processivity but not repeat addition processivity, resulting in a strong +6 product but no products longer than +6 (Figure 3B, lanes 7 and 8). In contrast, addition of the stem III-stem IV fusion (64-159 RNA) to RNP with 1-63 RNA rescued both nucleotide and repeat addition processivity (Figure 3B, lanes 9 and 10). These results demonstrate that stem III is not essential for nucleotide addition processivity but is important in conjunction with stem IV for repeat addition processivity. Addition of stem III alone (64-102 RNA) in trans to RNAs lacking stem III did not have an impact on nucleotide or repeat addition processivity (data not shown). In order to function, stem III must be covalently connected to another region of the RNA.

Figure 3. The Stem III Pseudoknot Cooperates with Stem IV in Repeat Addition Processivity.

Figure 3

(A) Secondary structure schematics are shown for the telomerase RNA regions combined for complementation analysis.

(B) TERT was assembled with 1-102 RNA (lanes 1–5) or 1-63 RNA (lanes 6–10). Subsequently, 0.5 μM or 2.5 μM of 103-159 RNA (lanes 2 and 3 and 7 and 8) or 64-159 RNA (lanes 4 and 5 and 9 and 10) was added to the activity assay. Repeat addition processivity (R.A.P.) is indicated relative to that of the wild-type enzyme.

Addition of 64-159 RNA to telomerase RNP assembled with 1-63 RNA provided the stem III pseudoknot and stem IV but also allowed formation of stem I. Stem I pairing does not appear essential for repeat addition processivity, because addition of stem IV without stem I in trans stimulated repeat addition processivity of RNPs assembled with either 1-107 or 1-102 RNA (Figure 2B). To assess a possible contribution of stem I to repeat addition processivity more directly, we assayed the activity of telomerase RNPs assembled with stem I variant RNAs (Figure S2A). Removing the bottom strand of stem I by 5′ truncation of the RNA or unpairing stem I by mutagenesis of the top or bottom strand decreased overall telomerase activity substantially (Figure S2B). The decrease in activity of the stem I variant RNAs was not simply a consequence of reduced TERT binding (Figure S2C). Although decreased in specific activity, RNPs with stem I variant RNAs retained high nucleotide and repeat addition processivity. These findings confirm that stem I is not necessary for nucleotide or repeat addition processivity, and that a decrease in overall activity does not necessarily impose a processivity defect.

Pairing of Both Helices of the Stem III Pseudoknot Is Important for Repeat Addition Processivity

Tetrahymena telomerase RNA stem III is believed to form a pseudoknot structure (Figure 4A) (ten Dam et al., 1991; Lingner et al., 1994). A pseudoknot structure 3′ of the template is also predicted to be present in vertebrate telomerase RNAs (Chen et al., 2000). Unlike other paired elements of telomerase RNA, the pseudoknot may not be stably or uniquely folded (Bhattacharyya and Blackburn, 1994; Sperger and Cech, 2001; Antal et al., 2002). It seems possible that the stem III region adopts alternate conformations at different times during the catalytic cycle of telomeric repeat synthesis.

Figure 4. Pseudoknot Structure Is Important for Repeat Addition Processivity.

Figure 4

(A) Black lines and black dots indicate predicted pseudoknot base-pairing interactions. Bold letters indicate nucleotides that were modified in the pseudoknot variant RNAs.

(B) Telomerase activity was assayed for RNPs assembled with wild-type telomerase RNA (lane 1), stem III deletions (lanes 2 and 3), sequence variants disrupting the base pairing of either pseudoknot stem (lanes 4 and 5 and 7 and 8), or complementary sequence variations restoring base-paired stems (lanes 6 and 9). Repeat addition processivity (R.A.P.) is indicated relative to that of the wild-type enzyme. The repeat addition processivity of RNP with CC77-78GG RNA could not be estimated due to the low level of activity.

To probe the roles of the two stems that compose the pseudoknot, we assayed the activity of RNPs assembled with pseudoknot variant RNAs. Deletion of large portions of the pseudoknot resulted in a decrease in overall activity as noted previously (Licht and Collins, 1999) and also a partial loss of repeat addition processivity (Figure 4B, lanes 2 and 3). The RNA variants AC70-71UG and GU85-86CA both disrupt the same two base pairs within the shorter helix of the pseudoknot (Figure 4A). RNPs assembled with either RNA possessed reduced activity and reduced repeat addition processivity (Figure 4B, lanes 4 and 5). Similarly, disrupting two base pairs in the longer helix of the pseudoknot also decreased activity and repeat addition processivity (Figure 4B, lanes 7 and 8). Compensatory changes that restored base pairing potential increased repeat addition processivity to wild-type levels (Figure 4B, lanes 6 and 9). RNPs with RNAs containing the CC77-78GG substitution had a lower level of activity than RNPs with other stem III variants regardless of the overall base pairing potential and the extent of repeat addition processivity (compare unpaired stem III variants in lanes 7 and 8 and paired stem III variants in lanes 1 and 9). These results suggest that pseudoknot pairing and stem sequence are both important for activity, while the pairing potential but not the sequence of both stems of the pseudoknot is required for optimal repeat addition processivity. Stem III variant RNAs had little if any impact on RNP nucleotide addition processivity, consistent with our finding that the pseudoknot region is dispensable for rescue of the nucleotide addition processivity defect of RNP with 1-63 RNA by stem IV addition in trans (Figure 3).

The Distal Loop of Stem IV Binds TERT Directly

One potential mechanism by which RNA elements could stimulate RNP catalytic function is by interaction with TERT. We examined whether progressively 3′ truncated telomerase RNAs were compromised for binding to TERT by assaying RNA coimmunoprecipitation with TERT. Truncations of the telomerase RNA 3′ end up to position 63 did not result in a dramatic decrease in TERT binding (Figure 5B, lanes 2 and 3; data not shown). Removing additional regions, we found that both the TRE (positions 52 to 63) and the template (positions 43 to 51) were important for optimal TERT binding (Figure 5B, lanes 3–5). A finer 3′ truncation series suggested that within the TRE, positions 59 to 63 were the most critical (Figure S3). An RNA including only positions 1 to 42, containing an intact TBE but lacking both template and TRE, showed little binding to TERT at the sub-micromolar RNA concentration used in the coimmunoprecipitation assay (Figure 5B, lane 5). These results suggest that an interaction occurs between the TRE and TERT. This TERT-TRE interaction must occur with substantially lower affinity than the TERT-TBE interaction, because only TBE substitutions have a dramatic impact on TERT association in the context of full-length RNA (Lai et al., 2002). A weak interaction is consistent with the requirement for a micromolar concentration of RNA oligonucleotide containing TRE and template sequence for function in trans with the rest of the RNA body (Miller and Collins, 2002).

Figure 5. Low-Affinity TERT-Telomerase RNA Interactions at the TRE and Stem IV.

Figure 5

(A) The secondary structure of telomerase RNA with truncated RNA 3′ end positions and TERT interaction sites summarized. A schematic is also shown for cp107-42 RNA (a linker sequence connects the wild-type 5′ and 3′ RNA ends).

(B) TERT protein was immunopurified after assembly with the indicated telomerase RNA variants; bound RNAs were recovered and analyzed by blot hybridization. TERT binding is quantitated relative to wild-type RNA.

(C) Stem IV has a distributed TERT interaction site. TERT protein was immunopurified after assembly with circularly permuted telomerase RNAs that lacked the TRE and pseudoknot; bound RNAs were recovered and analyzed by blot hybridization. TERT binding is quantitated relative to cp107-42 RNA. Tetraloop indicates UUCG substitution of the indicated positions.

Our demonstration that stem IV is functional when added in trans to an RNP preassembled from TERT and a template-containing RNA (Figure 2) suggested that stem IV might also engage in an interaction with TERT. If so, the affinity provided by association of stem IV and TERT could be masked when the TBE, template, and TRE are all present on the same RNA molecule. To test whether stem IV contains a low-affinity TERT interaction element similar to the TRE, we generated an RNA containing stem IV and the TBE but lacking the TRE and template. To do this, we synthesized a circularly per- muted (cp) RNA with 5′ end at position 107 and 3′ end at position 42 (Figure 5A) with the wild-type 5′ and 3′ ends connected through a linker (Miller and Collins, 2002). The cp107-42 RNA bound to TERT much more strongly than 1-42 RNA lacking stem IV (Figure 5B, compare lanes 5 and 6), indicating that stem IV can increase the association of telomerase RNA with TERT in combination with the TBE motif. In order to delineate the position of the TERT binding element within stem IV, other circularly permuted telomerase RNAs that lacked the template and TRE were tested. Substitutions of the distal end of stem IV with a tetraloop (Figure 5C, lanes 2 and 3) or removal of most of the upper strand of stem IV without deletion of the loop (Figure 5C, lane 5) each slightly but reproducibly decreased TERT interaction. These findings suggest that both the paired region and the loop of stem IV contribute to TERT binding. This implies that a larger region of stem IV is involved in promoting TERT association than participates in establishing nucleotide and repeat addition processivity. Removal of either individual stem III region hairpin or disruption of either pseudoknot stem pairing had no substantial impact on TERT interaction in any context examined (data not shown).

The coimmunoprecipitation data above strongly suggests but does not prove that stem IV binds directly to TERT. An RNA-RNA interaction could instead have recruited stem IV to TERT and could be the mechanism of stem IV loop function in elongation processivity. To determine if the region of stem IV critical for influencing RNP catalytic function contacts TERT directly, an RNA with photoreactive thiouracil substitutions in the stem IV loop was utilized in a TERT crosslinking assay. RNA with thiouracil substitutions was created by ligation of a synthetic oligonucleotide to a circularly permuted RNA lacking the stem IV loop (Figure 6A). RNP assembled with the unsubstituted control cp143-142 RNA produced a pattern of product DNA similar to that of the wild-type enzyme (Figure 6B, lane 1). RNP with 4-thiouracil substitutions in RNA stem IV had wild-type nucleotide addition processivity and at least some repeat addition processivity (Figure 6B, lane 2). Radiolabeled telomerase RNA with thiouracil substitutions at positions 137 and 138 crosslinked to TERT in a UV-dependent manner (Figure 6C, lanes 3 and 4), while RNA without thiouracil substitutions did not crosslink to TERT under the same conditions (Figure 6C, lanes 1 and 2). The crosslink analyzed by SDS-PAGE was verified as a covalent association with TERT using several criteria. Most notably, mock reactions omitting TERT did not produce the crosslink and truncated TERT proteins changed the crosslink mobility (data not shown). This crosslinking analysis supports the coimmunoprecipitation assay in demonstrating that the loop of stem IV makes a direct contact to TERT. A similar crosslinking analysis with RNA bearing a thiouracil substitution at TRE position 57 or 62 demonstrated that TERT also directly contacts the TRE motif (Figure S4).

Figure 6. Stem IV Contacts TERT Directly.

Figure 6

(A) Secondary structure of the cpRNA tested for TERT crosslinking. The ligated oligonucleotide region is shown in outline.

(B) Activity assays were performed for RNPs assembled with cp143-142 RNA without 4-thiouracil substitution (lane 1) or with 4-thiouracil substitutions (lane 2).

(C) Crosslinking was performed by UV irradiation at approximately 366 nm for 15 min and was followed by sample separation on a 10% SDS-PAGE gel. Migration of the RNA-TERT complex and RNA alone species are indicated by arrows.

Discussion

RNA Functions in the Telomerase Catalytic Cycle

The catalytic cycle of telomeric repeat synthesis by telomerase involves a complex transit of template, substrates, and product through the active site (Figure 7). Product synthesis is initiated by appropriate positioning of a primer 3′ end, template, and dNTP in the active site (Figure 7, top). Correct placement of the stem IV distal loop, involving its association with TERT (Figure 7, right), stimulates processive nucleotide addition to the template 5′ boundary (Figure 7, bottom). Stem IV RNA could have a direct role in the positioning of primer, dNTP, or template. Alternately, stem IV RNA could function as an allosteric activator of TERT, favoring the productive positioning of a template-paired dNTP or primer 3′ end in the active site.

Figure 7. Proposed Roles for Telomerase RNA in the Telomerase Catalytic Cycle.

Figure 7

When assayed in vitro, telomerase enzymes from some organisms direct many rounds of repeat synthesis per primer binding event. Recent evidence suggests that at least in mammalian cells, processive repeat addition is a critical feature of telomere length maintenance (Pascolo et al., 2002). To accomplish reiterative repeat addition, a product 3′ end extended by synthesis to the template 5′ end must dissociate from the template, reestablish hybridization with a repositioned template 3′ end, and return to productive engagement in the active site (Figure 7). The stem III pseudoknot pairing could undergo a dynamic structural rearrangement as a part of this process (Figure 7, left). Analysis of the protection of Tetrahymena telomerase RNA residues from chemical modification in vitro revealed that stem IV and TERT influence the folding of the pseudoknot region (Sperger and Cech, 2001). Transient distortion of the pseudoknot induced by template threading through the active site could create a conformational change in the RNP that promotes product dissociation from the template. The template, now free from product hybridization, would return to default positioning. Pseudoknot refolding and formation of a repositioned primer-template hybrid could then again favor proper placement of the product 3′ end in the active site.

Telomerase enzymes from different organisms are surprisingly divergent in TERT and telomerase RNA sequence as well as in the composition of proteins that direct the physiological pathways of RNP assembly, activation, and regulation (Weilbaecher and Lundblad, 1999). The lack of conservation of telomerase RNA primary sequence makes it difficult to assign functions described here for the Tetrahymena telomerase RNA to telomerase RNAs from yeasts or mammals. The human telomerase RNA contains a region 3′ of the template (positions 253 to 318) that like Tetrahymena stem IV can interact directly with TERT to complement the activity defect of a 3′ truncated, template-bearing RNA fragment (Mitchell and Collins, 2000). In addition, all telomerase RNAs with mapped secondary structure are predicted by phylogenetic comparison to possess a pseudoknot 3′ of the template. Pseudoknot pairing is critical for ciliate telomerase RNA function in vivo (Gilley and Blackburn, 1999) and is important for in vivo reconstitution of mammalian telomerase activity (Martin-Rivera and Blasco, 2001). Investigation of the putative functional conservation of nontemplate telomerase RNA motifs will require future studies with telomerase enzymes from many additional species.

A Model for the Evolutionary Specialization of Telomerase RNP

Our present understanding of TERT and telomerase RNA roles in the RNP suggests a possible step-wise process of telomerase evolutionary specialization. Assuming that TERT evolved from an ancestral reverse transcriptase protein (Nakamura and Cech, 1998), its ability to synthesize telomeric repeats may first have required a mechanism to specify what RNA should serve as template. The TRE element could have served this role, correctly positioning any adjacent sequence as intended template (Miller and Collins, 2002). To improve the accuracy of repeat synthesis, a sharply defined 5′ template boundary could have evolved next, conferred by RNA sequences 5′ of the template (Tzfati et al., 2000; Lai et al., 2002). Acquisition of the TBE motif could have simultaneously established the 5′ template boundary and produced a more stable RNP. This telomerase RNP predecessor would have been specialized for accurate synthesis of a specific sequence repeat. The RNA component, initially only serving template-related functions, could next have acquired additional motifs that stimulated RNP nucleotide and repeat addition processivity. Nucleotide and repeat addition processivity are both critical for telomerase elongation efficiency. In addition, these aspects of catalytic function may also be critical for establishing the proper permutation of the most distal telomeric repeat and thereby the structure of the chromosome 3′ terminus.

Expanded Roles for RNA in the Modern RNP World

RNPs formed with non-protein coding (nc) RNAs have been implicated in almost every aspect of cellular function, including DNA replication, chromatin organization, transcription, translation, intracellular and intercellular trafficking, signal transduction, and oncogenic transformation. Bioinformatic methods fall short of readily identifying ncRNA genomic loci, implying that many additional ncRNA transcripts remain to be identified (Eddy, 2001). Our demonstration here that the RNA subunit of telomerase RNP has roles in specifying the catalytic features of DNA synthesis expands the known repertoire of ncRNA function. It is likely that the versatile roles of telomerase RNA will be echoed in future studies of noncoding RNA functions in other RNPs.

Experimental Procedures

Telomerase RNA Synthesis

Template DNAs for 5′ and 3′ telomerase RNA truncations, stem IV variants, and stem III and stem IV RNAs added in trans were generated by PCR from pT7159 DNA. Circularly permuted RNAs were generated by PCR from TER perm A1 DNA, which encodes for two telomerase RNA molecules in tandem with their 5′ and 3′ ends connected by a 5′-TTTTGGATCC-3′ linker sequence (Miller and Collins, 2002). Stem I and stem III truncations and sequence variants were generated by site-specific mutagenesis of pT7159 DNA. Wild-type telomerase RNA and all telomerase RNA derivatives contain a 5′ guanosine leader to increase transcription efficiency.

Telomerase RNAs were synthesized in vitro by T7 transcription and gel-purified. RNA concentration was determined by UV spectrophotometry and/or fluorometry. The position 128-142 and position 123-146 stem IV RNAs were synthesized chemically (Dharmacon, Lafayette, CO).

Telomerase Activity Assay

For each activity assay, 4 to 10 μl of rabbit reticulocyte lysate (RRL) coupled transcription and translation reaction (Promega) expressing HA-tagged TERT was assembled with 4 pmole of telomerase RNA at 30°C for 15 min. The complex was immunopurified on Protein G Sepharose (Amersham Pharmacia) with HA antibody. The activity assay contained as buffer 50 mM Tris-acetate (pH 8.0), 10 mM spermidine, 5 mM β-mercaptoethanol, and 2 mM MgCl2. To initiate the reaction, 250 μM TTP, 3.5 μM unlabeled dGTP, 1.2 μM 32P-dGTP (800 Ci/mmol), and 2 μM of the primer (TG)8TTGGG were added. The reactions were incubated at 30°C for 20 min followed by phenol:chloroform:isoamyl alcohol extraction and ethanol precipitation. The radiolabeled DNA products were resolved by denaturing gel electrophoresis. For the activity assays using telomerase RNA truncations added in trans, TERT was assembled with the template-containing RNA and immunopurified as described above and then mixed with the indicated amount of trans-complementing RNA in the activity assay reaction. Repeat addition processivity was calculated by determining the percentage of product extended past the first repeat on a molar basis (approximately 18% for wild-type enzyme under the reaction conditions used here).

TERT-Telomerase RNA Binding Assay

Ten microliters of RRL expressing HA-tagged TERT was mixed with 0.56 pmole of telomerase RNA, 5 μg of BSA, and 5 μg of tRNA, and then incubated at 30°C for 20 min. Samples were incubated with 15 μl of Protein G Sepharose with HA antibody in 400 μl of T2MG (20 mM Tris-HCl [pH 8.0], 1 mM MgCl2, and 10% glycerol) with 100 mM NaCl for 4 hr at 4°C. TERT complex bound to the beads was washed with T2MG + 100 mM NaCl, extracted with phenol:chloroform:isoamyl alcohol, and ethanol precipitated. Bound RNA was then separated by denaturing gel electrophoresis and transferred to Hybond N+ (Amersham Pharmacia) for hybridization analysis. The RNA was probed with a 32P-labeled DNA oligonucleotide complementary to the RNA sequence 5′ of the template. Quantification was performed by PhosphorImager analysis.

Crosslinking of TERT-Telomerase RNA Complexes

The 4-thiouracil substituted telomerase RNAs were made by enzymatic ligation of a longer T7 RNA polymerase transcript and a shorter, chemically synthesized oligonucleotide using standard methods (Moore and Query, 2000). Full-length, 32P-labeled ligation product was gel-purified from the ligation reaction. HA-tagged TERT protein was synthesized in RRL and assembled with telomerase RNA at 30°C. The complex was immunopurified on Protein G Sepharose with HA antibody in T2MG with no salt. Crosslinking by UV irradiation was done at approximately 366 nm for 15 min. Sample buffer was then added followed by SDS-PAGE.

Supplementary Material

supplementary

Figure S1

Product profile is independent of reaction time for enzymes defective in nucleotide and repeat addition processivity. RNPs immunopurified after assembly with the indicated telomerase RNA variant were pre-warmed to 30°C. After initiation of the reaction, aliquots were withdrawn into stop solution after 1, 5 and 20 minutes. Quantitation of the low level of activity of RNP with 1-63 RNA was not reliable.

Figure S2

Stem I is important for telomerase RNP overall activity but not elongation processivity. (A) The structure of stem I is shown including RNA positions 1-11 and 102-108. Bold letters indicate changes made in stem I variant RNAs. Dots indicate predicted base pairing interactions and crosses indicate disrupted base pairing interactions. (B) Activity assays were performed for TERT assembled with wild-type telomerase RNA (lane 1), 5′ telomerase RNA truncations (lanes 2–5) or stem I sequence variants (lanes 6–8). The ‘bot comp’ RNA has a CCCGC4-8GGGCG substitution and the ‘top comp’ RNA has a GCGGG103-107CGCCC substitution. The ‘bot/top comp’ RNA has both of these sequence changes. (C) TERT protein was mixed with the indicated telomerase RNA variants and then immunopurified. TERT binding is quantitated relative to wild-type RNA.

Figure S3

A region of the TRE improves the association of 3′ truncated telomerase RNAs with TERT. (A) Schematic of the telomerase RNA template and TRE indicates 3′ end positions of the RNA truncations tested. (B) TERT protein was immunopurified after assembly with the indicated telomerase RNA variants; bound RNAs were recovered and analyzed by blot hybridization. TERT binding is quantitated relative to 1-103 RNA.

Figure S4

The TRE directly contacts TERT. (A) Activity assays were performed for TERT assembled with cp64-42 RNA without oligonucleotide ligation (lane 2), cp64-63 RNA derived from unsubstituted oligonucleotide ligation (lane 1), or cp64-63 RNAs with 4-thiouracil substitution at either position 57 or position 62 within the TRE (lanes 3–4). (B) Crosslinking was performed by UV irradiation at approximately 366 nm for 15 minutes and was followed by sample separation on a 10% SDS-PAGE gel. Migration of the RNA-TERT complex and RNA alone species are indicated by arrows.

Acknowledgments

We thank members of the Collins laboratory and Steph Yonker for discussion on this manuscript. Chemically synthesized RNAs were produced by Dharmacon (Lafayette, CO). This work was supported by a National Institutes of Health Grant (GM54198) to K.C.

References

  1. Antal M, Boros E, Solymosy F, Kiss T. Analysis of the structure of human telomerase RNA in vivo. Nucleic Acids Res. 2002;30:912–920. doi: 10.1093/nar/30.4.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhattacharyya A, Blackburn EH. Architecture of telomerase RNA. EMBO J. 1994;13:5721–5731. doi: 10.1002/j.1460-2075.1994.tb06910.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bhattacharyya A, Blackburn EH. A functional telomerase RNA swap in vivo reveals the importance of nontemplate RNA domains. Proc Natl Acad Sci USA. 1997;94:2823–2827. doi: 10.1073/pnas.94.7.2823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blackburn EH. The end of the (DNA) line. Nat Struct Biol. 2000;7:847–850. doi: 10.1038/79594. [DOI] [PubMed] [Google Scholar]
  5. Bosoy D, Lue NF. Functional analysis of conserved residues in the putative “finger” domain of telomerase reverse transcriptase. J Biol Chem. 2001;276:46305–46312. doi: 10.1074/jbc.M108168200. [DOI] [PubMed] [Google Scholar]
  6. Bryan TM, Goodrich KJ, Cech TR. A mutant of Tetrahymena telomerase reverse transcriptase with increased processivity. J Biol Chem. 2000a;275:24199–24207. doi: 10.1074/jbc.M003246200. [DOI] [PubMed] [Google Scholar]
  7. Bryan TM, Goodrich KJ, Cech TR. Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol Cell. 2000b;6:493–499. doi: 10.1016/s1097-2765(00)00048-4. [DOI] [PubMed] [Google Scholar]
  8. Chan SW, Blackburn EH. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene. 2002;21:553–563. doi: 10.1038/sj.onc.1205082. [DOI] [PubMed] [Google Scholar]
  9. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomerase RNA. Cell. 2000;100:503–514. doi: 10.1016/s0092-8674(00)80687-x. [DOI] [PubMed] [Google Scholar]
  10. Cohn M, Blackburn EH. Telomerase in yeast. Science. 1995;269:396–400. doi: 10.1126/science.7618104. [DOI] [PubMed] [Google Scholar]
  11. de Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532–540. doi: 10.1038/sj.onc.1205080. [DOI] [PubMed] [Google Scholar]
  12. Eddy SR. Non-coding RNA genes and the modern RNA world. Nat Rev Genet. 2001;2:919–929. doi: 10.1038/35103511. [DOI] [PubMed] [Google Scholar]
  13. Gilley D, Blackburn EH. The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein. Proc Natl Acad Sci USA. 1999;96:6621–6625. doi: 10.1073/pnas.96.12.6621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Greider CW. Telomerase is processive. Mol Cell Biol. 1991;11:4572–4580. doi: 10.1128/mcb.11.9.4572-4580.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 1989;337:331–337. doi: 10.1038/337331a0. [DOI] [PubMed] [Google Scholar]
  16. Hammond PW, Cech TR. dGTP-dependent processivity and possible template switching of Euplotes telomerase. Nucleic Acids Res. 1997;25:3698–3704. doi: 10.1093/nar/25.18.3698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hardy CD, Schultz CS, Collins K. Requirements for the dGTP-dependent repeat addition processivity of recombinant Tetrahymena telomerase. J Biol Chem. 2001;276:4863–4871. doi: 10.1074/jbc.M005158200. [DOI] [PubMed] [Google Scholar]
  18. Hossain S, Singh S, Lue NF. Functional analysis of the C-terminal extension of telomerase reverse transcriptase. A putative “thumb” domain. J Biol Chem. 2002;277:36174–36180. doi: 10.1074/jbc.M201976200. [DOI] [PubMed] [Google Scholar]
  19. Kelleher C, Teixeira MT, Forstemann K, Lingner J. Telomerase: biochemical considerations for enzyme and substrate. Trends Biochem Sci. 2002;27:572–579. doi: 10.1016/s0968-0004(02)02206-5. [DOI] [PubMed] [Google Scholar]
  20. Lai CK, Mitchell JR, Collins K. RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol. 2001;21:990–1000. doi: 10.1128/MCB.21.4.990-1000.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lai CK, Miller MC, Collins K. Template boundary definition in Tetrahymena telomerase. Genes Dev. 2002;16:415–420. doi: 10.1101/gad.962602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Licht JD, Collins K. Telomerase RNA function in recombinant Tetrahymena telomerase. Genes Dev. 1999;13:1116–1125. doi: 10.1101/gad.13.9.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lingner J, Hendrick LL, Cech TR. Telomerase RNAs of different ciliates have a common secondary structure and a permuted template. Genes Dev. 1994;8:1984–1998. doi: 10.1101/gad.8.16.1984. [DOI] [PubMed] [Google Scholar]
  24. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 1997;276:561–567. doi: 10.1126/science.276.5312.561. [DOI] [PubMed] [Google Scholar]
  25. Livengood AJ, Zaug AJ, Cech TR. Essential regions of Saccharomyces cerevisiae telomerase RNA: separate elements for Est1p and Est2p interaction. Mol Cell Biol. 2002;22:2366–2374. doi: 10.1128/MCB.22.7.2366-2374.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Maine IP, Chen S, Windle B. Effect of dGTP concentration on human and CHO telomerase. Biochemistry. 1999;38:15325–15332. doi: 10.1021/bi991596+. [DOI] [PubMed] [Google Scholar]
  27. Martin-Rivera L, Blasco MA. Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J Biol Chem. 2001;276:5856–5865. doi: 10.1074/jbc.M008419200. [DOI] [PubMed] [Google Scholar]
  28. Miller MC, Collins K. Telomerase recognizes its template using and adjacent RNA motif. Proc Natl Acad Sci USA. 2002;99:6585–6590. doi: 10.1073/pnas.102024699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Miller MC, Liu JK, Collins K. Template definition by Tetrahymena telomerase reverse transcriptase. EMBO J. 2000;19:4412–4422. doi: 10.1093/emboj/19.16.4412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mitchell JR, Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol Cell. 2000;6:361–371. doi: 10.1016/s1097-2765(00)00036-8. [DOI] [PubMed] [Google Scholar]
  31. Moore MJ, Query CC. Joining of RNAs by splinted ligation. Methods Enzymol. 2000;317:109–123. doi: 10.1016/s0076-6879(00)17009-0. [DOI] [PubMed] [Google Scholar]
  32. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529. doi: 10.1016/0092-8674(89)90035-4. [DOI] [PubMed] [Google Scholar]
  33. Nakamura TM, Cech TR. Reversing time: origin of telomerase. Cell. 1998;92:587–590. doi: 10.1016/s0092-8674(00)81123-x. [DOI] [PubMed] [Google Scholar]
  34. Pascolo E, Wenz C, Lingner J, Hauel N, Priepke H, Kauffmann I, Garin-Chesa P, Rettig WJ, Damm K, Schnapp A. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. J Biol Chem. 2002;277:15566–15572. doi: 10.1074/jbc.M201266200. [DOI] [PubMed] [Google Scholar]
  35. Peng Y, Mian IS, Lue NF. Analysis of telomerase activity processivity: mechanistic similarity to HIV-1 reverse transcriptase and role in telomere maintenance. Mol Cell. 2001;7:1201–1211. doi: 10.1016/s1097-2765(01)00268-4. [DOI] [PubMed] [Google Scholar]
  36. Peterson SE, Stellwagen AE, Diede SJ, Singer MS, Haimberger ZW, Johnson CO, Tzoneva M, Gottschling DE. The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku. Nat Genet. 2001;27:64–67. doi: 10.1038/83778. [DOI] [PubMed] [Google Scholar]
  37. Prescott J, Blackburn EH. Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro. Genes Dev. 1997;11:528–540. doi: 10.1101/gad.11.4.528. [DOI] [PubMed] [Google Scholar]
  38. Prowse KR, Avilion AA, Greider CW. Identification of a nonprocessive telomerase activity from mouse cells. Proc Natl Acad Sci USA. 1993;90:1493–1497. doi: 10.1073/pnas.90.4.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Romero DP, Blackburn EH. A conserved secondary structure for telomerase RNA. Cell. 1991;67:343–353. doi: 10.1016/0092-8674(91)90186-3. [DOI] [PubMed] [Google Scholar]
  40. Roy J, Fulton TB, Blackburn EH. Specific telomerase RNA residues distant from the template are essential for telomerase RNA function. Genes Dev. 1998;12:3286–3300. doi: 10.1101/gad.12.20.3286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Seto AG, Livengood AJ, Tzfati Y, Blackburn EH, Cech TR. A bulged stem tethers Est1p to telomerase RNA in budding yeast. Genes Dev. 2002;16:2800–2812. doi: 10.1101/gad.1029302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sperger JM, Cech TR. A stem-loop of Tetrahymena telomerase RNA distant from the template potentiates RNA folding and telomerase activity. Biochemistry. 2001;40:7005–7016. doi: 10.1021/bi0103359. [DOI] [PubMed] [Google Scholar]
  43. ten Dam E, van Belkum A, Pleij K. A conserved pseudoknot in telomerase RNA. Nucleic Acids Res. 1991;19:6951. doi: 10.1093/nar/19.24.6951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tzfati Y, Fulton TB, Roy J, Blackburn EH. Template boundary in a yeast telomerase specified by RNA structure. Science. 2000;288:863–867. doi: 10.1126/science.288.5467.863. [DOI] [PubMed] [Google Scholar]
  45. Weilbaecher RG, Lundblad V. Assembly and regulation of telomerase. Curr Opin Chem Biol. 1999;3:573–577. doi: 10.1016/s1367-5931(99)00011-3. [DOI] [PubMed] [Google Scholar]
  46. Yu G, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature. 1990;344:126–132. doi: 10.1038/344126a0. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplementary

Figure S1

Product profile is independent of reaction time for enzymes defective in nucleotide and repeat addition processivity. RNPs immunopurified after assembly with the indicated telomerase RNA variant were pre-warmed to 30°C. After initiation of the reaction, aliquots were withdrawn into stop solution after 1, 5 and 20 minutes. Quantitation of the low level of activity of RNP with 1-63 RNA was not reliable.

Figure S2

Stem I is important for telomerase RNP overall activity but not elongation processivity. (A) The structure of stem I is shown including RNA positions 1-11 and 102-108. Bold letters indicate changes made in stem I variant RNAs. Dots indicate predicted base pairing interactions and crosses indicate disrupted base pairing interactions. (B) Activity assays were performed for TERT assembled with wild-type telomerase RNA (lane 1), 5′ telomerase RNA truncations (lanes 2–5) or stem I sequence variants (lanes 6–8). The ‘bot comp’ RNA has a CCCGC4-8GGGCG substitution and the ‘top comp’ RNA has a GCGGG103-107CGCCC substitution. The ‘bot/top comp’ RNA has both of these sequence changes. (C) TERT protein was mixed with the indicated telomerase RNA variants and then immunopurified. TERT binding is quantitated relative to wild-type RNA.

Figure S3

A region of the TRE improves the association of 3′ truncated telomerase RNAs with TERT. (A) Schematic of the telomerase RNA template and TRE indicates 3′ end positions of the RNA truncations tested. (B) TERT protein was immunopurified after assembly with the indicated telomerase RNA variants; bound RNAs were recovered and analyzed by blot hybridization. TERT binding is quantitated relative to 1-103 RNA.

Figure S4

The TRE directly contacts TERT. (A) Activity assays were performed for TERT assembled with cp64-42 RNA without oligonucleotide ligation (lane 2), cp64-63 RNA derived from unsubstituted oligonucleotide ligation (lane 1), or cp64-63 RNAs with 4-thiouracil substitution at either position 57 or position 62 within the TRE (lanes 3–4). (B) Crosslinking was performed by UV irradiation at approximately 366 nm for 15 minutes and was followed by sample separation on a 10% SDS-PAGE gel. Migration of the RNA-TERT complex and RNA alone species are indicated by arrows.

RESOURCES